Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Cellectis is implementing good security practices.
Read more about the latest issues in cybersecurity
Data breaches occur when information security and data security are compromised, resulting in ...
Ransomware is a type of malicious software, or malware, designed to deny access to a computer ...
Compare Cellectis's security performance with other companies